47 results
8-K
EX-99.1
CTMX
CytomX Therapeutics Inc
8 May 24
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
oncology R&D, including T-cell engagers, ADCs, and cytokines. CytomX’s leadership and continuous innovation in the field of masked, conditionally
8-K
EX-99.1
5ppxeplfeoq sem
8 Aug 23
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
EX-99.1
0pzls
9 May 23
CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:12pm
8-K
EX-99.1
cw403419nquqtytx
4 Aug 22
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
4:12pm
424B5
dynavvhkkig10x u50
4 Mar 22
Prospectus supplement for primary offering
5:22pm
8-K
1ydsahqk
14 Feb 22
Departure of Directors or Certain Officers
4:16pm
8-K
EX-99.1
etp6cyp1yl7hfharibbs
10 Jan 22
Regulation FD Disclosure
8:00am